Stay updated on Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.5.3 to v3.5.4, signaling a maintenance update. No study content or functionality appears to be altered.
    Difference
    0.1%
    Check dated 2026-05-18T03:48:11.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    This updates the page’s software/UI revision marker from **v3.5.0** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-26T15:32:25.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    UI refresh of the study details page with updated layout and navigation; core study information such as eligibility criteria and outcomes remains unchanged.
    Difference
    0.0%
    Check dated 2026-04-12T11:17:24.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; previous revision v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-21T20:23:05.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Footer text updated from Revision: v3.4.2 to Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T13:21:31.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.4.2 instead of Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T17:39:44.000Z thumbnail image

Stay in the know with updates to Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.